Zepbound

About Zepbound

Zepbound (tirzepatide) is a dual GLP-1/GIP receptor agonist indicated for chronic weight management in adults with obesity or overweight. Clinical studies show it can help individuals lose 15-21% of their body weight in about a year and a half. Patients report both significant weight loss and appetite changes while some may experience side effects such as nausea. Zepbound is intended to be used in conjunction with a reduced-calorie diet and increased physical activity.

What to know before choosing a GLP-1 Clinic in N/A, N/A

When researching glp-1 clinic providers in N/A, N/A, patients should verify licensing, medical direction, and whether the clinic follows FDA-compliant sourcing for peptides, hormones, and regenerative therapies. The Kindr Directory independently indexes GLP-1 Clinic listings across United States and flags providers that have verified their credentials. Below is the public profile for Zepbound, sourced from open web data and augmented with Kindr's verification checks.

• Verify state medical licensure and, where applicable, DEA registration for Zepbound.
• Confirm whether Zepbound uses a 503A or 503B compounding pharmacy for peptide and hormone therapies.
• Ask about telehealth availability across N/A — many longevity clinics in N/A, N/A now offer hybrid care.
• Request published pricing for injectable, oral, and lab-based protocols before booking a consult.

Products & Services

• Weight Loss Management
• Prescription for Zepbound
• Lifestyle Counseling

Credentials & Licensing

Frequently asked about Zepbound